Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 1;4(9):1287-1288.
doi: 10.1001/jamaoncol.2018.1258.

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer

Robert D Timmerman  1 , Chen Hu  2   3 , Jeff M Michalski  4 , Jeffrey C Bradley  4 , James Galvin  5 , David W Johnstone  6 , Hak Choy  1
Affiliations

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer

Robert D Timmerman et al. JAMA Oncol. .

Abstract

This study evaluates 5-year data from the NRG Oncology RTOG 0236 trial on the effects of sterotactic body radiation therapy in patients with inoperable stage I non–small cell lung cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Research grants for clinical trials have been provided to Dr Timmerman’s institutions form Varian Medical Systems, Elekta Oncology, and Accuray Inc. No other disclosures are reported.

Figures

Figure 1.
Figure 1.. Patterns of Failure Among 23 Patients Experiencing Progression on NRG Oncology RTOG 0236
Distant indicates uninvolved lobes of the lung and extrathoracic sites (15 failures); local, primary tumor and involved lobe (13 failures [4 primary tumor and 9 involved lobe]); and regional, hilar or mediastinal lymph nodes (7 failures).
Figure 2.
Figure 2.. Five-Year Survival
Overall survival (OS) and disease-free survival (DFS) from time of randomization.
See this image and copyright information in PMC

References

    1. Timmerman R, Paulus R, Galvin J, et al. . Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070-1076. - PMC - PubMed
    1. Pan H, Rose BS, Simpson DR, Mell LK, Mundt AJ, Lawson JD. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol. 2013;36(3):269-272. - PMC - PubMed
    1. ClinicalTrials.gov Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non–Small Cell Lung Cancer. NCT00087438. https://clinicaltrials.gov/ct2/show/NCT00087438. Accessed March 27, 2018.
    1. Yang W, Jones R, Lu W, et al. . Feasibility of non-coplanar tomotherapy for lung cancer stereotactic body radiation therapy. Technol Cancer Res Treat. 2011;10(4):307-315. - PubMed
    1. Trotti A, Colevas AD, Setser A, et al. . CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176-181. - PubMed